Showing the single result
Afatinib Tablets
FreeProduct Composition & Strength
We supply this product in multiple strengths to allow for precise dose titration based on patient tolerability.
Active Ingredient Strength Primary Clinical Function Afatinib (as Dimaleate) USP/Ph.Eur. 20 mg / 30 mg The Dose-Adjustment Unit: Used for patients requiring a lower dose due to gastrointestinal or skin toxicity. Afatinib (as Dimaleate) USP/Ph.Eur. 40 mg The Standard Therapeutic Anchor: The globally validated starting dose for first-line treatment of EGFR+ NSCLC. Excipients Proprietary Matrix Bio-Stable Coating: Engineered to protect the sensitive dimaleate salt and ensure consistent systemic absorption.
